Market Closed -
Hong Kong S.E.
04:08:20 2024-04-26 am EDT
|
5-day change
|
1st Jan Change
|
0.34
HKD
|
-11.69%
|
|
+4.62%
|
+25.93%
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Capitalization
1 |
664.7
|
742.4
|
600.5
|
367.6
|
622.8
|
445.1
|
Enterprise Value (EV)
1 |
316.9
|
-247.4
|
-552.3
|
-804.7
|
-553.9
|
-709.7
|
P/E ratio
|
-4.51
x
|
-38.4
x
|
-10.2
x
|
-12.5
x
|
75
x
|
-495
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
1.13
x
|
4.58
x
|
7.53
x
|
9.33
x
|
16.3
x
|
2.86
x
|
EV / Revenue
|
0.54
x
|
-1.53
x
|
-6.92
x
|
-20.4
x
|
-14.5
x
|
-4.56
x
|
EV / EBITDA
|
12.4
x
|
582
x
|
27.5
x
|
50.7
x
|
39
x
|
-178
x
|
EV / FCF
|
-3.55
x
|
-0.56
x
|
-2.62
x
|
-21.5
x
|
31.1
x
|
65.7
x
|
FCF Yield
|
-28.2%
|
-179%
|
-38.1%
|
-4.64%
|
3.22%
|
1.52%
|
Price to Book
|
0.54
x
|
0.62
x
|
0.52
x
|
0.33
x
|
0.55
x
|
0.4
x
|
Nbr of stocks (in thousands)
|
840,000
|
840,000
|
840,000
|
840,000
|
840,000
|
840,000
|
Reference price
2 |
0.7913
|
0.8839
|
0.7149
|
0.4377
|
0.7415
|
0.5299
|
Announcement Date
|
4/26/18
|
4/26/19
|
4/28/20
|
4/26/21
|
4/28/22
|
4/27/23
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net sales
1 |
588.5
|
162.2
|
79.8
|
39.39
|
38.16
|
155.6
|
EBITDA
1 |
25.62
|
-0.425
|
-20.06
|
-15.88
|
-14.2
|
3.996
|
EBIT
1 |
22.08
|
-6.431
|
-22.58
|
-16.57
|
-14.73
|
3.769
|
Operating Margin
|
3.75%
|
-3.97%
|
-28.3%
|
-42.08%
|
-38.61%
|
2.42%
|
Earnings before Tax (EBT)
1 |
24.69
|
-14.24
|
-56.23
|
-29.35
|
8.3
|
0.156
|
Net income
1 |
-147.4
|
-19.36
|
-58.62
|
-29.35
|
8.3
|
-0.899
|
Net margin
|
-25.04%
|
-11.93%
|
-73.46%
|
-74.51%
|
21.75%
|
-0.58%
|
EPS
2 |
-0.1754
|
-0.0230
|
-0.0698
|
-0.0349
|
0.009880
|
-0.001070
|
Free Cash Flow
1 |
-89.32
|
442.9
|
210.6
|
37.37
|
-17.83
|
-10.79
|
FCF margin
|
-15.18%
|
273.06%
|
263.94%
|
94.87%
|
-46.72%
|
-6.94%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
4/26/18
|
4/26/19
|
4/28/20
|
4/26/21
|
4/28/22
|
4/27/23
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
348
|
990
|
1,153
|
1,172
|
1,177
|
1,155
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-89.3
|
443
|
211
|
37.4
|
-17.8
|
-10.8
|
ROE (net income / shareholders' equity)
|
2.76%
|
-1.42%
|
-4.99%
|
-2.59%
|
0.74%
|
-0.08%
|
ROA (Net income/ Total Assets)
|
0.73%
|
-0.26%
|
-1.11%
|
-0.82%
|
-0.74%
|
0.19%
|
Assets
1 |
-20,320
|
7,335
|
5,300
|
3,578
|
-1,125
|
-473.9
|
Book Value Per Share
2 |
1.470
|
1.430
|
1.360
|
1.330
|
1.340
|
1.330
|
Cash Flow per Share
2 |
0.4400
|
1.240
|
1.430
|
1.450
|
1.450
|
1.430
|
Capex
1 |
0.02
|
0.22
|
0.01
|
0.09
|
0.01
|
0.02
|
Capex / Sales
|
0%
|
0.13%
|
0.01%
|
0.24%
|
0.01%
|
0.01%
|
Announcement Date
|
4/26/18
|
4/26/19
|
4/28/20
|
4/26/21
|
4/28/22
|
4/27/23
|
|
1st Jan change
|
Capi.
|
---|
| +25.93% | 43M | | +10.59% | 8.7B | | +29.45% | 2.21B | | -0.24% | 1.18B | | +24.85% | 883M | | -2.50% | 808M | | -14.90% | 600M | | +3.40% | 594M | | -2.33% | 565M | | -8.50% | 553M |
Purification & Treatment Equipment
|